VenoStent Enrolls First Subjects in 200-Subject US Clinical Trial
VenoStent Enrolls First Subjects in 200-Subject US Clinical Trial
Source: pr-inside.com
Tim Boire News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Tim Boire. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Tim Boire Today - Breaking & Trending Today
VenoStent Closes $16M Series A Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
VenoStent Completes $16M Series A Financing, Receives IDE Approval ...
VenoStent Completes $16M Series A Financing, Receives IDE Approval ...
Source: pr-inside.com
VenoStent Technology Receives Breakthrough Device Designation by FDA
Designation to promote more rapid Agency and market access for VenoStentHOUSTON, TX / ACCESSWIRE / May 17, 2022 / VenoStent, Inc., a clinical-stage tissue engineering company developing bioabsorbable perivascular
Source: finanznachrichten.de
VenoStent Announces $2.3M in Seed Funding to Transform Vascular Access Surgery for Hemodialysis Patients
VenoStent Announces $2.3M in Seed Funding to Transform Vascular Access Surgery for Hemodialysis Patients Share Article Creative Ventures leads the funding round, with participation from IAG Capital Partners "While we are laser-focused on our first indication, hemodialysis access, what’s additionally so exciting is that this approach avails to us a whole host of potential applications in ‘perivascular wrapping,’" said Geoff Lucks, VenoStent’s Co-Founder and COO. NASHVILLE, Tenn. (PRWEB) February 23, 2021 VenoStent, a Houst...
Source: prweb.com